Artemis DNA will begin offering groundbreaking cutting-edge genetic testing and early cancer detection technology to the people of Vietnam. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity
Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical
Furthering its strong commitment to ESG initiatives, clinical diagnostic laboratory company becomes first U.S. corporate customer for EV-maker VinFast with reservation for 100 vehicles. Irvine, Calif., January 8, 2022 — Artemis
Irvine, Calif., November 30, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic
Irvine, Calif., November 30, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic
Irvine, Calif., November 4, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and
Irvine, Calif., October 12, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic
Irvine, Calif., August 9, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and
